Zum Inhalt springen

Nur-Lesen-Fassung: Das Forschungsinformationssystem (FIS) ist aus Sicherheitsgründen vorübergehend durch diese Nur-Lesen-Fassung ersetzt. Alle öffentlichen Inhalte und Volltexte sind weiterhin abrufbar; Anmeldung, Bearbeitung, Einreichung und Statistiken stehen nicht zur Verfügung. Bei Fragen: fis@uni-bamberg.de

Start › Publikationen › Relationship Between Lipohypertrophy, Glycemic Control, and Insulin Dosing : A Systematic Meta-Analysis

Publikation

Relationship Between Lipohypertrophy, Glycemic Control, and Insulin Dosing : A Systematic Meta-Analysis

Mader, Julia K.; Fornengo, Ricardo; Hassoun, Ahmed; u. a. (2026): Relationship Between Lipohypertrophy, Glycemic Control, and Insulin Dosing : A Systematic Meta-Analysis, in: Bamberg: Otto-Friedrich-Universität, S. 351–362.

Details

Fakultät/Lehrstuhl
Autorin(nen)/Autor(en)
Mader, Julia K.; Fornengo, Ricardo; Hassoun, Ahmed; Heinemann, Lutz; Kulzer, Bernhard; Monica, Magdalena; Nguyen, Trung; Jochen Sieber; Renard, Eric; Reznik, Yves; Ryś, Przemysław; Stożek-Tutro, Anita; Wilmot, Emma G.
Verlagsangabe
Otto-Friedrich-Universität : Bamberg
Erscheinungsjahr
2026
Quelle/Weitere Ausgabe
Diabetes Technology & Therapeutics, Larchmont, NY: Liebert, 2024, Jg. 26, Nr. 5, S. 351–362, ISSN: 1520-9156
Jahr der Erstpublikation
2024
Sprache(n)
Englisch
Lizenz
URN
Abstract

Background: Lipohypertrophy is a common complication in patients with diabetes receiving insulin therapy. There is a lack of consensus regarding how much lipohypertrophy affects diabetes management. Our study aimed to assess the potential correlation between lipohypertrophy and glycemic control, as well as insulin dosing in patients with diabetes. Methods: We performed a systematic review followed by a meta-analysis to collect data about glycemic control and insulin dosing in diabetic patients with and without lipohypertrophy. To identify relevant studies published in English, we searched medical databases (MEDLINE/PubMed, Embase, and CENTRAL) from 1990 to January 20, 2023. An additional hand-search of references was performed to retrieve publications not indexed in medical databases. Results of meta-analyses were presented either as prevalence odds ratios (pORs) or mean differences (MDs) with 95% confidence intervals (95% CIs). This study was registered on PROSPERO (CRD42023393103). Results: Of the 5540 records and 240 full-text articles screened, 37 studies fulfilled the prespecified inclusion criteria. Performed meta-analyses showed that patients with lipohypertrophy compared with those without lipohypertrophy were more likely to experience unexplained hypoglycemia (pOR [95% CI] =6.98 [3.30– 14.77]), overall hypoglycemia (pOR [95% CI] =6.65 [1.37–32.36]), and glycemic variability (pOR [95%CI] =5.24 [2.68–10.23]). Patients with lipohypertrophy also had higher HbA1c (MD [95% CI] =0.55 [0.23–

0.87] %), and increased daily insulin consumption (MD [95% CI] =7.68 IU [5.31–10.06]). Conclusions: These results suggest that overall glycemic control is worse in patients with lipohypertrophy than in those without this condition.

Freie Schlagwort(e)
Diabetes
Glycemic Control
Insulin-injection technique
Lipohypertrophy
Meta-analysis
Systematic review
DDC-Klassifikation
150 Psychologie
RVK-Klassifikation
CU 3000
Peer Reviewed
ja
Internationale Verbreitung
ja
Open-Access-Zeitschrift
ja
Dokumenttyp
Artikel in einer Zeitschrift / Postprint
URI
Datum der Freischaltung
20.02.2026

Permalink: https://fis.uni-bamberg.de/handle/uniba/113072 · Daten als JSON · Zitieren: BibTeX · RIS

Datenstand: 16.11.2026

Eingeschränkter Lesezugriff: Anmeldung, Bearbeitung und Einreichung sind vorübergehend deaktiviert.